Applied DNA Sciences Granted US Patent for Identification of Genetic Variants of Pima Cotton - Seite 2

Dr. James Hayward, President and CEO of APDN commented: "This is an extraordinarily valuable extension of our Intellectual Property portfolio. fiberTyping is in wide use to detect noncompliance with specifications when upland cotton is substituted for ELS. Now pimaTyping will allow us to identify source when non-American ELS is substituted for the American cultivar. Our portfolio allows us to diagnose supply chain problems in cotton with genotyping; we can then future-proof the supply chain with SigNature T marking as we have already demonstrated."

With SigNature T marking and authentication, suppliers of cotton to the US military can prove their cotton is of American origin, in compliance with the Berry Amendment, which applies generally to textiles and apparel which gives preference to government suppliers who use American-grown cotton.

About Applied DNA Sciences

We make life real and safe by providing botanical-DNA based security and authentication solutions and services that can help protect products, brands, entire supply chains, and intellectual property of companies, governments and consumers from theft, counterfeiting, fraud and diversion. SigNature^® DNA describes the platform ingredient that is at the heart of all of our security and authentication solutions. SigNature DNA is at the core of a family of uncopyable products such as DNAnet^®, our anti-theft product, SigNature^® T, targeted toward textiles, and digitalDNA^®, providing powerful track and trace. All provide a forensic chain of evidence and can be used to prosecute perpetrators.

Applied DNA Sciences is listed on the NASDAQ under the symbol APDN, and its warrants are listed under the symbol APDNW.

Forward-Looking Statement
The statements made by APDN in this press release may be "forward-looking" in nature within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K filed on December 15, 2014, which are available at www.sec.gov. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events, unless otherwise required by law.

investor contact:

Debbie Bailey
631-240-8817
Email contact

media contact:

Enrique Briz
Dian Griesel Int'l.
212- 825-3210
Email contact

program contact:

MeiLin Wan
631-240-8849
Email contact

web:Email contact 
twitter: @APDN